Tacrolimus 1 MG capsule (IR) 100S
Ended Awarded
- Contract number
- SPE2DB25FW95P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,585
Award facts
- Contract value 100% obligated
- $5,584.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,584.77 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate-release formulation) in quantities of 100 units. The contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical procurement contracts with the DLA and Defense Health Agency. Tacrolimus, an immunosuppressant medication, supports critical medical supply requirements for military and veteran healthcare systems. The company's federal contract awards demonstrate extensive capability in delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains, from specialty medications to vaccines and medical devices, through competitively awarded delivery orders with pricing ranging from minimal transactions to substantial orders. This delivery order represents a routine fulfillment under the company's established pharmaceutical prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DB25FW95P?
SPE2DB25FW95P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FW95P worth?
The government has obligated $5,585 on SPE2DB25FW95P.
Is contract SPE2DB25FW95P an order under another contract?
Yes. SPE2DB25FW95P is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW95P competed?
The extent of competition for SPE2DB25FW95P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award